Table 3.
Variable | Parameter | ||||||||
---|---|---|---|---|---|---|---|---|---|
|
|||||||||
u alpha1/creat | uNGAL | uAGE | |||||||
|
|||||||||
R-squared | Coef β | p | R-squared | Coef β | p | R-squared | Coef β | p | |
eGFR | 0.178 | -0.051 | <0.001 | 0.074 | -2.477 | 0.014 | 0.130 | -0.602 | 0.001 |
Cystatin C | 0.146 | 3.240 | <0.001 | 0.101 | 262.687 | 0.004 | 0.110 | 38.515 | 0.002 |
pAGE | 0.132 | 36.69 | 0.001 | 0.089 | 4.60 | 0.007 | 0.058 | 1.777 | 0.03 |
UACR | 0.292 | 0.035 | <0.001 | 0.282 | 3.398 | <0.0001 | 0.177 | 0.378 | <0.001 |
u alpha1/creat | 0.542 | 0.112 | <0.001 | 0.586 | 0.055 | <0.001 | |||
uNGAL/creat | 0.482 | 4.943 | <0.0001 |
u alpha1/creat: urinary alpha1-microglobulin to creatinine ratio; uNGAL/creat: urinary neutrophil gelatinase-associated lipocalin to creatinine ratio; uAGE: urinary advanced glycation end-products; eGFR: estimated glomerular filtration rate; pAGE: plasma advanced glycation end-products; UACR: urinary albumin to creatinine ratio.